Carlyle promotes Wise to global health care head

The Carlyle Group has promoted Stephen Wise to global head of its health care team. Wise joined Carlyle in 2006 from JLL Partners.


New York, NY – Global alternative asset manager The Carlyle Group (NASDAQ: CG) today announced that Stephen Wise has been promoted to Global Head of Carlyle’s Heath Care team, effective at the beginning of this year. Karen Bechtel, the founding group head who transitioned to co-head last year, continues as a Managing Director and maintain her service on a number of Carlyle portfolio company boards.

Ms. Bechtel and Mr. Wise have co-led the Health Care team for the past year. Since joining Carlyle in 2005, Ms. Bechtel has overseen a number of significant healthcare investments including MultiPlan, PPD, Healthscope and HCR-ManorCare, with the group under her leadership investing nearly $6 billion in equity.

Mr. Wise, a 10-year Carlyle veteran, has spent his entire Carlyle career working with Ms. Bechtel to produce Carlyle’s strong track record in the healthcare sector. He has led or been a key contributor to deals including Rede D’Or, Ortho-Clinical Diagnostics and PPD.

Allan Holt, Co-head of U.S. Buyout said, “Karen has been a fantastic investor and leader at Carlyle in terms of building a world-class investment team, generating an outstanding investment track record and establishing Carlyle as a global leader in healthcare investments. And we will continue to benefit from her excellent judgment and deep industry relationships.”

Peter Clare, Co-Head of U.S. Buyout and Carlyle Deputy CIO for Corporate Private Equity, said: “Steve is a proven investor and we expect that he will build upon the level of excellence that Karen has established.”
Ms. Bechtel came to Carlyle following a distinguished 28-year career at Morgan Stanley, where she was that firm’s first female partner and, among other roles, led health care investments as a member of the investment committee for the Morgan Stanley Capital Partners IV Fund; was Co-head of the Financial Sponsors Group; ran the Corporate Restructuring Group; was founder and head of Princes Gate Private Equity Investors, a $650 million bridge equity fund; and served as Managing Director in the Mergers and Acquisitions department.

Mr. Wise joined Carlyle’s Health Care team from New York-based private equity firm JLL Partners in 2006. At JLL, he focused on health care-related investments, reviewing and executed transactions in a wide variety of sectors, including facilities-based services, managed care and pharmaceutical services. Previously, he worked with J.W. Childs Associates, a Boston-based private equity firm, and prior to that, in the leveraged finance group of Credit Suisse.
* * * * *
About The Carlyle Group
The Carlyle Group (NASDAQ: CG) is a global alternative asset manager with $188 billion of assets under management across 126 funds and 160 fund of funds vehicles as of September 30, 2015. Carlyle’s purpose is to invest wisely and create value on behalf of its investors, many of whom are public pensions. Carlyle invests across four segments – Corporate Private Equity, Real Assets, Global Market Strategies and Investment Solutions – in Africa, Asia, Australia, Europe, the Middle East, North America and South America. Carlyle has expertise in various industries, including: aerospace, defense & government services, consumer & retail, energy, financial services, healthcare, industrial, real estate, technology & business services, telecommunications & media and transportation. The Carlyle Group employs more than 1,700+ people in 35 offices across six continents.